S'abonner

Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain - 24/09/21

Doi : 10.1016/j.ajog.2021.08.038 
Sawsan As-Sanie, MD, MPH a, , Sara R. Till, MD, MPH a, Andrew D. Schrepf, PhD b, d, Kendall C. Griffith, MD a, Alex Tsodikov, PhD c, Stacey A. Missmer, ScD e, Daniel J. Clauw, MD b, d, Chad M. Brummett, MD b, d
a Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 
b Department of Anesthesiology, University of Michigan, Ann Arbor, MI 
c Department of Biostatistics, University of Michigan, Ann Arbor, MI 
d Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI 
e Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI 

Corresponding author: Sawsan As-Sanie, MD, MPH.
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Friday 24 September 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Background

Chronic pelvic pain is a debilitating problem that afflicts 15% to 20% of women in the United States. Although more than 200,000 hysterectomies are performed annually for the treatment of chronic pelvic pain, previous studies indicate that 1 in 4 women undergo the discomfort and morbidity of hysterectomy without the relief of pain. The factors that predict treatment failure remain poorly characterized.

Objective

To describe the incidence of persistent pelvic pain 6 months following hysterectomy in women with chronic pelvic pain and determine whether a simple, self-reported measure of central sensitization is associated with a greater risk of persistent pelvic pain following hysterectomy.

Study Design

We conducted a prospective, observational cohort study of women undergoing hysterectomy at an academic tertiary care center for a benign indication. Patients with preoperative chronic pelvic pain, defined as average pelvic pain ≥3 on a 0 to 10 numeric rating scale for >3 months before hysterectomy, were included in this analysis. The patients completed validated assessments of pain, anxiety, depression, and centralized pain (using the 2011 Fibromyalgia Survey Criteria, 0–31 points) preoperatively and 6 months after hysterectomy. The demographic information, surgical history, intraoperative findings, and surgical pathology were abstracted from the electronic medical records. Multivariate logistic regression was used to identify the independent predictors of persistent pelvic pain 6 months following hysterectomy, defined as <50% improvement in pelvic pain severity.

Results

Among 176 participants with pelvic pain before hysterectomy, 126 (71.6%) were retained at 6 months, and 15 (11.9%) reported persistent pelvic pain. There was no difference in age (P=.46), race (P=.55), average pain severity during menses (P=.68), average overall pelvic pain (P=.10), or pain duration (P=.80) in those with and without persistent pelvic pain. Whereas intraoperative findings of endometriosis (P=.05) and uterine fibroids (P=.03) were associated with a higher incidence of persistent pain on univariate analysis, the surgical route (P=.46), pelvic adhesions (0.51), uterine weight (P=.66), and adenomyosis on histopathology (P=.27) were not related to the risk of persistent pain. Higher preoperative centralized pain scores (P=.01) but not depression (P=.64) or anxiety (P=.45) were more common in women with persistent pelvic pain. Multivariate logistic regression adjusting for age, preoperative pain severity, anxiety, depression, and operative findings of endometriosis and fibroids indicated that every 1-point increase in centralized pain before hysterectomy was associated with a 27% increase in the odds of persistent pelvic pain (odds ratio, 1.27; 95% confidence interval, 1.03–1.57) 6 months after surgery.

Conclusion

Although the majority of women with chronic pelvic pain report considerable improvement in pain following hysterectomy, higher degrees of centralized pain before hysterectomy is a robust predictor of persistent pelvic pain.

Le texte complet de cet article est disponible en PDF.

Key words : central sensitization, centralized pain, endometriosis, fibromyalgia, hysterectomy, nociplastic pain, pelvic pain, persistent pain


Plan


 S.A. is a consultant for AbbVie, Myovant, Bayer, and Eximis, and receives author royalties from UpToDate. C.M.B. is a consultant for Heron Therapeutics (San Diego, CA), Vertex Pharmaceuticals (Boston, MA), and Alosa Health (Boston, MA) and he provides expert testimony. S.A.M. is a consultant for AbbVie and Roche and currently receives grant funding from the National Institutes of Health (NIH), the Department of Defense, and AbbVie. The remaining authors report no conflict of interest.
 S.A. is supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development R01 HD088712. C.M.B. is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR060392, NIAMS P50 AR070600, National Institute on Drug Abuse (NIDA) R01DA038261, NIDA R01DA042859, and Common Fund UM1 NS118922. A.D.S. is supported, in part, by NIH R43 DA046981. S.R.T. is supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development 1K23HD09928301A1. Additional support has been received from the Department of Anesthesiology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
 Cite this article as: As-Sanie S, Till SR, Schrepf AD, et al. Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain. Am J Obstet Gynecol 2021;XX:x.ex–x.ex.


© 2021  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.